Published in Cancer Res on April 15, 1998
Deregulated proteolysis by the F-box proteins SKP2 and beta-TrCP: tipping the scales of cancer. Nat Rev Cancer (2008) 6.10
Dual mode of degradation of Cdc25 A phosphatase. EMBO J (2002) 1.95
Human Cdc25 A inactivation in response to S phase inhibition and its role in preventing premature mitosis. EMBO Rep (2000) 1.72
Clinical significance of CDC25A and CDC25B expression in squamous cell carcinomas of the oesophagus. Br J Cancer (2001) 1.04
Oncogenic potential of a C.elegans cdc25 gene is demonstrated by a gain-of-function allele. EMBO J (2002) 1.02
Increased mitotic rate coincident with transient telomere lengthening resulting from pim-1 overexpression in cardiac progenitor cells. Stem Cells (2012) 0.96
Anti-CDC25B autoantibody predicts poor prognosis in patients with advanced esophageal squamous cell carcinoma. J Transl Med (2010) 0.93
Cdc25B functions as a novel coactivator for the steroid receptors. Mol Cell Biol (2001) 0.90
Small interfering RNA targeting CDC25B inhibits liver tumor growth in vitro and in vivo. Mol Cancer (2008) 0.86
Expression of CDC25 phosphatases in human gastric cancer. Dig Dis Sci (2007) 0.81
Prognostic significance of CDC25B expression in gliomas. J Clin Pathol (2006) 0.79
Cdc25 as a potential target of anticancer agents. Invest New Drugs (2000) 0.78
CDC25A(Q110del): a novel cell division cycle 25A isoform aberrantly expressed in non-small cell lung cancer. PLoS One (2012) 0.77
High-risk human papillomavirus type 16 E7 oncogene associates with Cdc25A over-expression in oral squamous cell carcinoma. Virchows Arch (2006) 0.76
The anti-tumour agent, cisplatin, and its clinically ineffective isomer, transplatin, produce unique gene expression profiles in human cells. Cancer Inform (2008) 0.75
Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol (1986) 18.40
Stromal gene signatures in large-B-cell lymphomas. N Engl J Med (2008) 11.34
Chronic lymphocytic leukemia. N Engl J Med (1995) 4.52
Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology (2002) 4.22
Improved sex-specific criteria of left ventricular hypertrophy for clinical and computer interpretation of electrocardiograms: validation with autopsy findings. Circulation (1987) 3.16
International standardized approach for flow cytometric residual disease monitoring in chronic lymphocytic leukaemia. Leukemia (2007) 2.96
Placental pathology in malaria: a histological, immunohistochemical, and quantitative study. Hum Pathol (2000) 2.84
Criteria for grading in the Ljubljana classification of epithelial hyperplastic laryngeal lesions. A study by members of the Working Group on Epithelial Hyperplastic Laryngeal Lesions of the European Society of Pathology. Histopathology (1999) 2.76
Thalidomide in multiple myeloma: lack of response of soft-tissue plasmacytomas. Br J Haematol (2001) 2.75
Growth hormone treatment for sustained pain reduction and improvement in quality of life in severe fibromyalgia. Pain (2012) 2.69
BMI-1 gene amplification and overexpression in hematological malignancies occur mainly in mantle cell lymphomas. Cancer Res (2001) 2.57
HLA-identical sibling bone marrow transplantation in younger patients with chronic lymphocytic leukemia. European Group for Blood and Marrow Transplantation and the International Bone Marrow Transplant Registry. Ann Intern Med (1996) 2.52
Indications for allogeneic stem cell transplantation in chronic lymphocytic leukemia: the EBMT transplant consensus. Leukemia (2006) 2.38
Widespread synchronous [Ca2+]i oscillations due to bursting electrical activity in single pancreatic islets. Pflugers Arch (1991) 2.22
Applicability of the International Index for aggressive lymphomas to patients with low-grade lymphoma. J Clin Oncol (1994) 2.20
Massive chronic intervillositis of the placenta associated with malaria infection. Am J Surg Pathol (1998) 2.05
Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma. Leukemia (2007) 2.03
Organizing pneumonia in textile printing workers: a clinical description. Eur Respir J (1998) 2.03
ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL). Ann Oncol (2012) 2.03
Intensive chemotherapy (high-dose CHOP/ESHAP regimen) followed by autologous stem-cell transplantation in previously untreated patients with peripheral T-cell lymphoma. Ann Oncol (2008) 2.01
Mantle cell lymphoma: presenting features, response to therapy, and prognostic factors. Cancer (1998) 1.97
Generic RT-nested-PCR for detection of flaviviruses using degenerated primers and internal control followed by sequencing for specific identification. J Virol Methods (2005) 1.96
Aspirin and salicylate induce apoptosis and activation of caspases in B-cell chronic lymphocytic leukemia cells. Blood (1998) 1.93
WHO International Histological Classification of Tumours. Tentative Histological Classification of Salivary Gland Tumours. Pathol Res Pract (1990) 1.93
Adenosquamous carcinoma of the head and neck: criteria for diagnosis in a study of 12 cases. Histopathology (2004) 1.87
Placental malaria is associated with cell-mediated inflammatory responses with selective absence of natural killer cells. J Infect Dis (2001) 1.84
Peripheral T-cell lymphomas: initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the R.E.A.L. Classification. Ann Oncol (1998) 1.81
Influence of diuretics on the concentration of proteins and other components of pleural transudates in patients with heart failure. Am J Med (2001) 1.81
Differential expression of galectin 3 and galectin 1 in colorectal cancer progression. Gastroenterology (1997) 1.80
Renal failure in multiple myeloma: presenting features and predictors of outcome in 94 patients from a single institution. Arch Intern Med (1998) 1.79
The FOXP1 winged helix transcription factor is a novel candidate tumor suppressor gene on chromosome 3p. Cancer Res (2001) 1.76
International Consensus Conference on High-Dose Therapy with Hematopoietic Stem Cell Transplantation in Aggressive Non-Hodgkin's Lymphomas: report of the jury. J Clin Oncol (1999) 1.76
Short-term outcome analysis of a randomized study comparing laparoscopic vs open colectomy for colon cancer. Surg Endosc (1995) 1.74
Adenoid cystic carcinoma of the breast: mammographic appearance and pathologic correlation. AJR Am J Roentgenol (1998) 1.73
Immunohistochemical analysis of the immune reaction in the nervous system in paraneoplastic encephalomyelitis. Neurology (1990) 1.73
Evaluation of different criteria for the separation of pleural transudates from exudates. Chest (1993) 1.72
Sinonasal tubulopapillary low-grade adenocarcinoma. Histopathological, immunohistochemical and ultrastructural features of poorly recognised entity. Virchows Arch (2003) 1.68
Bilateral lymphocytic alveolitis: a common reaction after unilateral thoracic irradiation. Eur Respir J (1999) 1.68
ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia. Leukemia (2012) 1.68
Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants. Blood (1999) 1.66
Cancer of the pancreas induced in the Syrian golden hamster. Am J Pathol (1974) 1.65
Array-based DNA methylation profiling in follicular lymphoma. Leukemia (2009) 1.63
Evidence of the effectiveness of continuous positive airway pressure in the treatment of sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med (1999) 1.62
Survival after progression in patients with follicular lymphoma: analysis of prognostic factors. Ann Oncol (2002) 1.61
TRK-fused gene (TFG) is a new partner of ALK in anaplastic large cell lymphoma producing two structurally different TFG-ALK translocations. Blood (1999) 1.59
Development of aggressive plasma cell leukaemia under interferon-alpha therapy. Br J Haematol (1991) 1.59
Different effects of tolbutamide and diazoxide in alpha, beta-, and delta-cells within intact islets of Langerhans. Diabetes (1999) 1.55
ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma. Ann Oncol (2013) 1.51
Body weight gain after administration of antipsychotic drugs: correlation with leptin, insulin and reproductive hormones. Pharmacopsychiatry (2000) 1.47
[Pulmonary cavitation as the initial manifestation of Hodgkin's disease]. Med Clin (Barc) (1994) 1.47
Treatment of pulmonary disease caused by Mycobacterium kansasii: results of 18 vs 12 months' chemotherapy. Tuber Lung Dis (1995) 1.46
Sham continuous positive airway pressure for placebo-controlled studies in sleep apnoea. Lancet (1999) 1.45
SNP-based mapping arrays reveal high genomic complexity in monoclonal gammopathies, from MGUS to myeloma status. Leukemia (2012) 1.45
p16(INK4a) gene inactivation by deletions, mutations, and hypermethylation is associated with transformed and aggressive variants of non-Hodgkin's lymphomas. Blood (1998) 1.45
A new prognostic system for multiple myeloma based on easily available parameters. Br J Haematol (1989) 1.44
Chronic lymphocytic leukemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2011) 1.42
Cancer dissemination during laparoscopic surgery: tubes, gas, and cells. World J Surg (1998) 1.42
NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcome. Leukemia (2012) 1.41
Central nervous system involvement demonstrated by immunological study in prolymphocytic variant of chronic lymphocytic leukemia. Acta Haematol (1989) 1.41
Expectation maximization (EM) algorithms using polar symmetries for computed tomography (CT) image reconstruction. Comput Biol Med (2013) 1.41
[Chronic myeloid leukemia after renal transplantation: report of a new case and review of the bibliography]. Sangre (Barc) (1996) 1.41
Non-Hodgkin's lymphoma associated with Gaucher's disease. Leuk Lymphoma (1998) 1.41
Correlation between histological signs of placental underperfusion and perinatal morbidity in late-onset small-for-gestational-age fetuses. Ultrasound Obstet Gynecol (2015) 1.40
Mesonephric adenocarcinoma of the uterine corpus: CD10 expression as evidence of mesonephric differentiation. Am J Surg Pathol (2001) 1.39
The changing profile of Ph-positive chronic myeloid leukemia at presentation: possible impact of earlier diagnosis on survival. Haematologica (1999) 1.39
[Hepatic mesenchymatous hamartoma presenting in an adult patient]. Med Clin (Barc) (1995) 1.39
Chronic myeloid leukemia of thrombocythemic onset: a CML subtype with distinct hematological and molecular features? Leukemia (1996) 1.39
Acute myeloblastic leukemia with minimal myeloid differentiation: phenotypical and ultrastructural characteristics. Leukemia (1998) 1.39
Effect of melatonin on myocardial oxidative stress induced by experimental obstructive jaundice. Rev Esp Enferm Dig (2009) 1.38
Cathepsin B expression in colorectal carcinomas correlates with tumor progression and shortened patient survival. Am J Pathol (1994) 1.38
[Bronchiolitis obliterans with organized pneumonia secondary to gold salts]. Med Clin (Barc) (1993) 1.38
Hematopoietic stem cell transplantation in chronic lymphocytic leukemia: a report of 12 patients from a single institution. Ann Oncol (1998) 1.37
Increased gelatinase A (MMP-2) and cathepsin B activity in invasive tumor regions of human colon cancer samples. Am J Pathol (1994) 1.36
PRAD-1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma. Blood (1994) 1.36
Lymphomas expressing ALK fusion protein(s) other than NPM-ALK. Blood (1999) 1.35
PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. Cancer Res (1994) 1.34